These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12200806)

  • 1. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease.
    London R; Solis A; Goldberg GA; Wade S; Ryu S
    Am J Kidney Dis; 2002 Sep; 40(3):539-48. PubMed ID: 12200806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Healthcare expenditure and resource utilization in patients with anaemia and chronic kidney disease: a retrospective claims database analysis.
    Wish J; Schulman K; Law A; Nassar G
    Kidney Blood Press Res; 2009; 32(2):110-8. PubMed ID: 19372704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs.
    Wei SY; Chang YY; Mau LW; Lin MY; Chiu HC; Tsai JC; Huang CJ; Chen HC; Hwang SJ
    Nephrology (Carlton); 2010 Feb; 15(1):108-15. PubMed ID: 20377778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
    Lawler EV; Gagnon DR; Fink J; Seliger S; Fonda J; Do TP; Gaziano JM; Bradbury BD
    Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undertreatment of anemia in patients with chronic kidney disease in the United States: analysis of national outpatient survey data.
    Rasu RS; Manley HJ; Crawford T; Balkrishnan R
    Clin Ther; 2007 Jul; 29(7):1524-34. PubMed ID: 17825703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current management of renal anemia in patients with chronic kidney disease at the predialysis stage].
    Kuriyama S; Otsuka Y; Uetake D; Shirai I; Hosoya T
    Nihon Jinzo Gakkai Shi; 2007; 49(5):505-10. PubMed ID: 17695813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia management in chronic kidney disease.
    Gillespie BS; Inrig JK; Szczech LA
    Hemodial Int; 2007 Jan; 11(1):15-20. PubMed ID: 17257350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood transfusion use in non-dialysis-dependent chronic kidney disease patients aged 65 years and older.
    Ibrahim HN; Ishani A; Guo H; Gilbertson DT
    Nephrol Dial Transplant; 2009 Oct; 24(10):3138-43. PubMed ID: 19451656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predialysis Survey on Anemia Management: patient referral.
    Hörl WH; Macdougall IC; Rossert J; Rutkowski B; Wauters JP; Valderrábano F;
    Am J Kidney Dis; 2003 Jan; 41(1):49-61. PubMed ID: 12500221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug utilization and cost for erythropoiesis-stimulating agents in a long-term care resident population with chronic kidney disease.
    Lafeuille MH; Bailey RA; Vekeman F; Kilpatrick BS; Senbetta M; Piech CT; Lefebvre P
    Consult Pharm; 2010 Aug; 25(8):493-500. PubMed ID: 20736158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: a time and motion study.
    Schiller B; Doss S; DE Cock E; Del Aguila MA; Nissenson AR
    Hemodial Int; 2008 Oct; 12(4):441-9. PubMed ID: 19090867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease management programs for CKD patients: the potential and pitfalls.
    Rocco MV
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S56-63. PubMed ID: 19231762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.
    Lee H; Manns B; Taub K; Ghali WA; Dean S; Johnson D; Donaldson C
    Am J Kidney Dis; 2002 Sep; 40(3):611-22. PubMed ID: 12200814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for successfully managing the anemia of chronic kidney disease in the long-term care setting.
    Germain MJ
    Consult Pharm; 2008 Mar; 23 Suppl A():11-7. PubMed ID: 18454575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of attitude of physicians on updates in the management of anemia in chronic kidney disease patients - an eye-opener.
    Binnani PG
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1090. PubMed ID: 19861881
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of chronic kidney disease in Taiwan: room for quality improvement.
    Kuo HW; Tsai SS; Tiao MM; Liu YC; Yang CY
    J Nephrol; 2009; 22(5):654-61. PubMed ID: 19809999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists.
    Bacchus S; O'Mara N; Manley H; Fishbane S
    Ann Pharmacother; 2009 Nov; 43(11):1857-66. PubMed ID: 19826095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CKD surveillance using administrative data: impact on the health care system.
    Collins AJ; Chen SC; Gilbertson DT; Foley RN
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S27-36. PubMed ID: 19231758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.